CTXR
Price
$1.77
Change
-$0.16 (-8.29%)
Updated
Jul 9 closing price
Capitalization
19.78M
HYPD
Price
$10.79
Change
-$0.77 (-6.66%)
Updated
Jul 9 closing price
Capitalization
55.08M
Interact to see
Advertisement

CTXR vs HYPD

Header iconCTXR vs HYPD Comparison
Open Charts CTXR vs HYPDBanner chart's image
Citius Pharmaceuticals
Price$1.77
Change-$0.16 (-8.29%)
Volume$1.53M
Capitalization19.78M
Hyperion DeFi
Price$10.79
Change-$0.77 (-6.66%)
Volume$934.25K
Capitalization55.08M
CTXR vs HYPD Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. HYPD commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Buy and HYPD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (CTXR: $1.77 vs. HYPD: $10.79)
Brand notoriety: CTXR and HYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 45% vs. HYPD: 15%
Market capitalization -- CTXR: $19.78M vs. HYPD: $55.08M
CTXR [@Biotechnology] is valued at $19.78M. HYPD’s [@Biotechnology] market capitalization is $55.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileHYPD’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • HYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, HYPD is a better buy in the long-term than CTXR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 5 TA indicator(s) are bullish while HYPD’s TA Score has 2 bullish TA indicator(s).

  • CTXR’s TA Score: 5 bullish, 4 bearish.
  • HYPD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than HYPD.

Price Growth

CTXR (@Biotechnology) experienced а -15.71% price change this week, while HYPD (@Biotechnology) price change was -31.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

CTXR is expected to report earnings on May 14, 2025.

HYPD is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPD($55.1M) has a higher market cap than CTXR($19.8M). HYPD YTD gains are higher at: 7290.411 vs. CTXR (-55.750). HYPD has higher annual earnings (EBITDA): -39.11M vs. CTXR (-42.77M). HYPD has higher revenues than CTXR: HYPD (67.1K) vs CTXR (0).
CTXRHYPDCTXR / HYPD
Capitalization19.8M55.1M36%
EBITDA-42.77M-39.11M109%
Gain YTD-55.7507290.411-1%
P/E RatioN/AN/A-
Revenue067.1K-
Total Cash26.4KN/A-
Total Debt932KN/A-
FUNDAMENTALS RATINGS
CTXR vs HYPD: Fundamental Ratings
CTXR
HYPD
OUTLOOK RATING
1..100
3332
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10040
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3634
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (9) in the Pharmaceuticals Major industry is somewhat better than the same rating for HYPD (52). This means that CTXR’s stock grew somewhat faster than HYPD’s over the last 12 months.

HYPD's Profit vs Risk Rating (40) in the Pharmaceuticals Major industry is somewhat better than the same rating for CTXR (100). This means that HYPD’s stock grew somewhat faster than CTXR’s over the last 12 months.

CTXR's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as HYPD (100). This means that CTXR’s stock grew similarly to HYPD’s over the last 12 months.

HYPD's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as CTXR (36). This means that HYPD’s stock grew similarly to CTXR’s over the last 12 months.

HYPD's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CTXR (100). This means that HYPD’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXRHYPD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDEIY10.350.11
+1.07%
Redeia Corporacion SA
FRMUF4.35N/A
N/A
Firm Capital Property Trust
HAWLN14.89N/A
N/A
Hawaiian Electric Co., Inc.
HTSUY6.80N/A
N/A
Hisamitsu Pharmaceutical Co., Ltd.
ACFN16.72-0.97
-5.48%
Acorn Energy, Inc.

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with CTXR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
-6.66%
CTXR - HYPD
37%
Loosely correlated
-8.53%
QNTM - HYPD
35%
Loosely correlated
+1.75%
INKT - HYPD
34%
Loosely correlated
+1.13%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
30%
Poorly correlated
+2.35%
More